The EMA has now issued a draft guidance on quality aspects of phage therapy medicinal products. Rising antimicrobial resistance has renewed interest in bacteriophages to fight pathogens.
- A Multi-Omics Approach For Characterizing Clinical-Scale iPSC Batches
- Global Implications Of Zero Tariffs On Indian Pharma Exports To China
- Why Do So Few Cell Therapies Make The Leap From Lab To GMP?
- Process Validation: Working Toward Harmonization Of Terms Used To Identify Validation Lots
- Careful Outsourcing Proves Key To Targeted Protein Degradation Drug Development
- What Can The Tech Sector's 'Minimally Viable' Concept Teach Biopharma?
- What Biotech Sponsors Should Look For In A CDMO For Sterile Fill/Finish
- New Group Wants 'Phase-Appropriate' Thinking To Retire
ON-DEMAND WEBINARS
Clinical supply innovators from across the industry share their experiences and lessons learned as they work to normalize the use of adherence measurement tools and smart medicine packages.
Explore the opportunities to optimize your supply chain strategy and facilitate direct-to-site, direct-to-patient and hybrid services utilizing a global GMP depot network.
In this interactive discussion, IQVIA Technologies' IRT experts delve into real-world examples and practical AI applications.
Join Neta Bendelac from 4G Clinical and Limor Teomim from IMP CSS for an informative webinar as they explore how to mitigate the growing challenges faced as a result of the pandemic when it comes to DtP strategies and virtual trial design.
ARTICLES, APP NOTES, CASE STUDIES, & WHITE PAPERS
-
![electronic-medical-technology-GettyImages-1204743045]( "Benefits Of Electronic Labels: Investigational Medicinal Products")
Benefits Of Electronic Labels: Investigational Medicinal ProductsWhen a new therapeutic drug, medical device, vaccine, or other investigational medicinal product (IMP) is developed, learn why a label must be on its packaging that provides relevant and important information.
-
![supply chain checklist pharmaceuticals-GettyImages-1616023386]( "Revolutionizing Trial Supply Management With The Power Of Free Picking")
Revolutionizing Trial Supply Management With The Power Of Free PickingDiscover the power of SmartSignals RTSM’s new free picking feature, designed to revolutionize trial supply management by optimizing efficiency and reducing costs.
-
![stress frustrate doctor iStock-1040929824]( "My Worst Nightmare In RSTM: Accidental Unblinding")
My Worst Nightmare In RSTM: Accidental UnblindingLearn how collaborative efforts from study managers, supply managers, biostatisticians, designers, and clinicians can better protect the blind in clinical trials and prevent accidental unblinding.
-
![GettyImages-1296841039-video-conference-remote]( "Risk Mitigation In Direct-To-Patient Clinical Trials")
Risk Mitigation In Direct-To-Patient Clinical TrialsThe DTP model can help alleviate risks in patient enrollment (including diversity), retention, and adherence to study timelines and budgets. Explore how to ease trial troubles through DTP.
-
![Panademic Related Manufacturing Complications]( "Outsourcers Are Feeling Uneasy About Continuity Of Supply")
Outsourcers Are Feeling Uneasy About Continuity Of SupplyFind out how COVID-19 complications have picked up from the first year, with more outsourcers experiencing bigger obstacles when it comes to manufacturing, specifically with drug product.
-
![GettyImages-1350880819 epro]( "Adapting Drug Supply Strategies To Modern Study Models")
Adapting Drug Supply Strategies To Modern Study ModelsAdvancements like remote-access drug refrigerators and smart packaging highlight the need for patient-centric trial models that integrate virtual and site-based activities to meet diverse patient needs.
-
![Vaccine Manufacturing GettyImages-1384850913]( "GxP Inventory Enhances Supply Chain For Global Specialty Biotech Firm")
GxP Inventory Enhances Supply Chain For Global Specialty Biotech FirmDiscover how the simplification and digitization of clinical supply chain operations enhanced transparency, lowered risks and expenses, and optimized efficiency.
-
![gettyimages-946264212-170667a]( "Navigate Complex Ancillary Supply Sourcing Challenges")
Navigate Complex Ancillary Supply Sourcing ChallengesExplore the evolvement of the clinical trial landscape over recent years, as well as the new challenges that this poses for the clinical supply chain.
-
![Internet-Medical-Things-iStock-914789708]( "How Are You Labeling Your IP? Protect Your Clinical Trial With Distinct Treatment Numbers")
How Are You Labeling Your IP? Protect Your Clinical Trial With Distinct Treatment NumbersExplore why engaging randomization and trial supply management (RTSM) services early in study startup can help protect clinical trials and expose substantial efficiencies, effectively baking in practices that help streamline supply chains.
-
![GettyImages-1070902452-planning-tracking-packaging-shipment]( "Enhancing Quality And Efficiency Through Digitized Clinical Secondary Packaging Processes")
Enhancing Quality And Efficiency Through Digitized Clinical Secondary Packaging ProcessesExplore how an innovative software platform can be used to create customized, user-friendly applications to digitize clinical secondary packaging processes.
CATALENT CORNER
| Insights from Catalent's Clinical Supply Experts |
SPONSORED CONTENT
Impact Of Supplier Choice On APAC Clinical Trial Execution
Learn about strategies Asia-Pacific has become an increasingly complex and congested destination for clinical trials as local and global sponsors alike flock to the region to take advantage of its many benefits, including access to large patient pools. Choosing the right clinical packaging and supply chain partner to support these studies is critical and can vary significantly based upon what countries are involved and the types of services required.
